OptiBiotix Health Plc (OPTI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OptiBiotix Health Plc (OPTI) has a cash flow conversion efficiency ratio of -0.106x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-895.00K ≈ $-108.90 USD) by net assets (GBX8.42 Million ≈ $1.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is OptiBiotix Health Plc worth for the company's overall valuation and market capitalisation.
OptiBiotix Health Plc - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how OptiBiotix Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
OptiBiotix Health Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OptiBiotix Health Plc ranked by their cash flow conversion efficiency. Explore OptiBiotix Health Plc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Transense Technologies PLC
LSE:TRT
|
0.056x |
|
Blackbird PLC
LSE:BIRD
|
-0.118x |
|
BENO Holding AG
XETRA:BENH
|
N/A |
|
Eneraqua Technologies PLC
LSE:ETP
|
0.014x |
|
Digitalbox PLC
LSE:DBOX
|
0.027x |
|
Getech Group
LSE:GTC
|
0.039x |
|
EARNZ plc
LSE:EARN
|
-0.135x |
|
Kasikornbank Public Company Limited
F:TFBF
|
0.050x |
Annual Cash Flow Conversion Efficiency for OptiBiotix Health Plc (2008–2024)
The table below shows the annual cash flow conversion efficiency of OptiBiotix Health Plc from 2008 to 2024. View OPTI share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX8.40 Million ≈ $1.02K |
GBX-1.77 Million ≈ $-215.11 |
-0.211x | -22.32% |
| 2023-12-31 | GBX8.87 Million ≈ $1.08K |
GBX-1.53 Million ≈ $-185.79 |
-0.172x | -69.24% |
| 2022-12-31 | GBX10.90 Million ≈ $1.33K |
GBX-1.11 Million ≈ $-134.93 |
-0.102x | -18.11% |
| 2021-12-31 | GBX18.17 Million ≈ $2.21K |
GBX-1.56 Million ≈ $-190.37 |
-0.086x | -9.96% |
| 2020-12-31 | GBX11.85 Million ≈ $1.44K |
GBX-927.96K ≈ $-112.91 |
-0.078x | +77.37% |
| 2019-12-31 | GBX4.98 Million ≈ $606.08 |
GBX-1.72 Million ≈ $-209.67 |
-0.346x | -98.06% |
| 2018-11-30 | GBX7.06 Million ≈ $859.29 |
GBX-1.23 Million ≈ $-150.09 |
-0.175x | +29.81% |
| 2017-11-30 | GBX7.05 Million ≈ $857.26 |
GBX-1.75 Million ≈ $-213.32 |
-0.249x | +0.09% |
| 2016-11-30 | GBX5.00 Million ≈ $608.74 |
GBX-1.25 Million ≈ $-151.61 |
-0.249x | +3.34% |
| 2015-11-30 | GBX3.82 Million ≈ $464.39 |
GBX-983.46K ≈ $-119.66 |
-0.258x | -69.62% |
| 2014-11-30 | GBX4.65 Million ≈ $565.66 |
GBX-706.24K ≈ $-85.93 |
-0.152x | +95.33% |
| 2013-11-30 | GBX115.88K ≈ $14.10 |
GBX-376.79K ≈ $-45.84 |
-3.251x | -33.04% |
| 2012-07-31 | GBX440.35K ≈ $53.58 |
GBX-1.08 Million ≈ $-130.94 |
-2.444x | -4398.03% |
| 2010-07-31 | GBX773.00K ≈ $94.05 |
GBX-42.00K ≈ $-5.11 |
-0.054x | +32.29% |
| 2009-07-31 | GBX810.00K ≈ $98.55 |
GBX-65.00K ≈ $-7.91 |
-0.080x | -145.20% |
| 2008-07-31 | GBX825.00K ≈ $100.38 |
GBX-27.00K ≈ $-3.29 |
-0.033x | -- |
About OptiBiotix Health Plc
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more